NCT06315010
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06315010
Title Repotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain Metastasis (REPOSE)
Acronym REPOSE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors MedSIR
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP | DEU | AUT

Facility Status City State Zip Country Details
Medizinische Universität Graz RECRUITING Graz Austria Details
Medical University of Vienna RECRUITING Vienna Austria Details
Ludwig-Maximilians-University Munich RECRUITING München Germany Details
Hospital de Vinalopó RECRUITING Elche Alicante Spain Details
Hospital Universitari Vall d'Hebron RECRUITING Barcelona Barcelona Spain Details
UOMI Cancer Center RECRUITING Barcelona Barcelona Spain Details
Institut Català d' Oncologia Girona (ICO) RECRUITING Girona Girona Spain Details
Hospital Beata María Ana RECRUITING Madrid Madrid Spain Details
Hospital Universitari Sant Joan de Reus RECRUITING Reus Tarragona Spain Details
Hospital General Universitario Dr. Balmis RECRUITING Alicante Spain Details
Hospital de Cruces RECRUITING Barakaldo Spain Details
Hospital Universitario de León RECRUITING León Spain Details
Hospital Lucus Agusti RECRUITING Lugo Spain Details
Hospital Universitario Vithas Madrid La Milagrosa RECRUITING Madrid Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca RECRUITING Murcia Spain Details
Complejo Hospitalario Universitario de Santiago (CHUS) RECRUITING Santiago de Compostela Spain Details
Hospital Clínico Universitario de Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field